Our months-long series about hepatitis C, "At the Crossroads: The Rise of Hepatitis C and the Fight to Stop It," has officially come to an end. We had a great public forum ("Hepatitis C: Cost, Cure, and Challenge") last night at Brown University, some key takeaways from which I'll share, below.
The stories continue
But first: the series may be over, but the stories of patients living with this chronic disease, the stories of people in the depths of addiction, putting themselves at risk of catching hepatitis C any time they share a needle or drug paraphernalia, the stories of doctors and nurses and public health workers and researchers on the front lines and in the trenches, fighting this disease, all those stories continue. And I'll keep you posted.
Read more...
Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.
For more information on how to use this blog, the HCV drug pipeline, and for more information on HCV clinical trials click here
Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.
Alan Franciscus
Editor-in-Chief
HCV Advocate
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment